Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2000
10/26/2000WO2000031120A3 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis
10/26/2000WO2000028045A3 Human hydrolase proteins
10/26/2000WO2000027815A3 N-substituted azacycles, their preparation and their use as orl-1 receptor ligands
10/26/2000WO2000020601A3 Polyketide synthase enzymes and recombinant dna constructs therefor
10/26/2000WO2000017191A3 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
10/26/2000WO2000017190A3 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
10/26/2000DE19918325A1 Extruded drug dosage form, e.g. granulate for tableting, comprising an active agent in a polysaccharide-containing matrix, giving a release profile which is controllable by extrusion conditions and/or the inclusion of additives
10/26/2000DE19918211A1 New 2-carbocyclyl-benzimidazole-carboxamide derivatives, are PARP inhibitors useful e.g. for treating neurodegenerative disease, epilepsy, ischemia, tumors, inflammation or diabetes
10/26/2000CA2373359A1 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes
10/26/2000CA2371976A1 A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof
10/26/2000CA2371972A1 Ent-steroids as selectively active estrogens
10/26/2000CA2370884A1 Single nucleotide polymorphisms in mitochondrial genes that segregate with alzheimer's disease
10/26/2000CA2370721A1 Neurotrophin potentiators
10/26/2000CA2370684A1 Use of rubidium and in particular rubidium chloride as an antimanic agent and stabilizer for mood swings
10/26/2000CA2370659A1 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof
10/26/2000CA2370570A1 Dna encoding the human vanilloid receptor vr1
10/26/2000CA2370417A1 Substituted azoles
10/26/2000CA2370129A1 Methods and compositions for modulating an immune response
10/26/2000CA2370127A1 Novel method of treatment
10/26/2000CA2370126A1 Estrogen receptor-.beta. ligands
10/26/2000CA2369078A1 Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk
10/26/2000CA2368839A1 D-form polypeptide which induces immune tolerance and methods of use
10/26/2000CA2368815A1 Novel synthesis and crystallization of piperazine ring-containing compounds
10/26/2000CA2367356A1 New compounds, their preparation and use
10/26/2000CA2365579A1 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv)
10/26/2000CA2365434A1 Angiogenic growth factors for treatment of peripheral neuropathy
10/26/2000CA2364209A1 49 human secreted proteins
10/26/2000CA2363689A1 Compounds useful as phosphotyrosine mimics
10/25/2000EP1045908A2 Human urotensin ii
10/25/2000EP1045850A1 Purine compounds having pde iv inhibitory activity and methods of synthesis
10/25/2000EP1045849A1 Purine derivatives having phosphodiesterase iv inhibition activity
10/25/2000EP1045845A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
10/25/2000EP1045842A2 Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines
10/25/2000EP1045839A2 Novel amines as pharmaceutical agents
10/25/2000EP1045834A1 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
10/25/2000EP1045833A1 2,3-substituted indole compounds as cox-2 inhibitors
10/25/2000EP1045830A1 Alpha-aminoamide derivatives useful as analgesic agents
10/25/2000EP1045826A1 Process for the preparation of isopropyl-methyl- 2-(3-n-propoxyphenoxy)ethyl]amine
10/25/2000EP1045822A1 Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments
10/25/2000EP1045693A1 Aminophenoxyacetic acid derivatives as neuroprotectants
10/25/2000EP1045690A1 Benzenesulfonamide inhibitors of pde-iv and their therapeutic use
10/25/2000EP0736039B1 Compounds with growth hormone releasing properties
10/25/2000EP0720601B1 Gastrin and cck receptor ligands
10/25/2000CN1271360A 1,3-dioxolo/4,5-Hl/2,3/benzodiazepine derivatives as AMPA/Kainate receptor inhibitors
10/25/2000CN1271359A Novel compounds
10/25/2000CN1271354A Compounds possessing neuronal activity
10/25/2000CN1271353A Furansulfonic acid derivatives and pharmaceutical compositions containing the same
10/25/2000CN1271347A 1,5-diphenylpypazole derivatives
10/25/2000CN1271278A Treatment of conduct disorder
10/25/2000CN1271251A 2-methyl-thieno-benzodiazepine formulation
10/25/2000CN1271250A Polyamine treatment of neurological disorders
10/25/2000CN1270959A 4-phenyl pyridine derivatives
10/25/2000CN1057760C Amino acid substituted benzoylguanidines, process for their preparation, their use and medicament containing them
10/25/2000CN1057676C Medicine for encephalatrophy and preparing method
10/24/2000US6136974 Pyrrolo[3,4-D]Pyrimidinone derivatives and their use as medicaments
10/24/2000US6136864 Denaturants for sympathomimetic amine salts
10/24/2000US6136862 Intravenously administering an organic acid, ester, or salt thereof
10/24/2000US6136861 Bicyclo[2.2.1]heptanes and related compounds
10/24/2000US6136859 Mixture of selenmethionine, carotene, ascorbic acid, tocopherol, methionine and coenzyme q10 in a carrier
10/24/2000US6136839 Using a sulfone or sulfoamide benzene compound
10/24/2000US6136828 Endothelin receptor antagonists
10/24/2000US6136825 Sulfonamide compounds having 5-HT receptor activity
10/24/2000US6136824 1-piperidinyl-propan-2-derivatives and their use as therapeutic agents
10/24/2000US6136819 Annelated dihydropyridines and the use thereof for preparing pharmaceutical preparations
10/24/2000US6136817 Opioid receptor antagonist compounds
10/24/2000US6136812 Methods of administering AMPA receptor antagonists to treat dyskinesias associated with dopamine agonist therapy
10/24/2000US6136805 Quinoxaline dione derivatives, their production and their use in medicaments
10/24/2000US6136803 Cycloalkyl ether indanamine compounds
10/24/2000US6136572 Recombinant KAT enzyme and process for its preparation
10/24/2000US6136532 Methods for treating bipolar mood disorder associated with markers on chromosome 18q
10/24/2000US6136332 Dermatological/pharmaceutical compositions comprising volatile oils/phenylated silicone oils
10/24/2000CA2157247C Physical form of dihydro-2,3-benzodiazepine derivative
10/24/2000CA2137445C Naphtalene derivates, process for their preparation and pharmaceutical compositions containing them
10/24/2000CA2072283C Process for the preparation of diacetylrhein
10/19/2000WO2000062068A1 Method to type prion proteins
10/19/2000WO2000062067A1 Novel transduction molecules and methods for using same
10/19/2000WO2000061779A1 49 human secreted proteins
10/19/2000WO2000061774A2 Bone morphogenic proteins
10/19/2000WO2000061755A2 Secreted human proteins
10/19/2000WO2000061754A2 Human proteins and polynucleotides encoding them
10/19/2000WO2000061750A2 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS
10/19/2000WO2000061743A1 Apoptosis-associated gene
10/19/2000WO2000061628A1 49 human secreted proteins
10/19/2000WO2000061627A1 49 human secreted proteins
10/19/2000WO2000061620A1 49 human secreted proteins
10/19/2000WO2000061609A2 Prodrugs of thrombin inhibitors
10/19/2000WO2000061608A2 Low-molecular inhibitors of complement proteases
10/19/2000WO2000061606A1 Novel human voltage-gated potassium channel
10/19/2000WO2000061604A2 Pharmaceutical compounds
10/19/2000WO2000061596A1 50 human secreted proteins
10/19/2000WO2000061587A1 Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
10/19/2000WO2000061583A1 Xanthine derivatives and analogs as cell signaling inhibitors
10/19/2000WO2000061576A1 Triarylimidazoles
10/19/2000WO2000061571A1 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors
10/19/2000WO2000061562A1 Neurotrophic substituted pyrimidines
10/19/2000WO2000061558A1 Remedies for neuropathic pain
10/19/2000WO2000061557A1 4-hydroxypiperidine derivatives having antiarrhythmic effect
10/19/2000WO2000061554A1 1-amino ethylindole derivatives for the treatment of urinary incontinence
10/19/2000WO2000061553A1 2-aminoethyl-indole derivatives, their preparation and therapeutic use
10/19/2000WO2000061542A1 Caspase inhibitors and the use thereof